Luca Galli - Concepedia

Author

Luca Galli

Azienda Ospedaliera Universitaria Pisana ORCID

Also Known As

Daniele Galanti, Galati, G., Galli Luca, Galli, L., Galli, Luca, Gianluca Del Conte, L GALLI, L Galli, L. GALLI, L. Galli

340

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliera Universitaria Pisana Istituti di Ricovero e Cura a Carattere Scientifico Fondazione IRCCS Istituto Nazionale dei Tumori Istituto Oncologico Veneto Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

About

Luca Galli is an author at Azienda Ospedaliera Universitaria Pisana specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	33	1.1K
2	Engineering	2	2	293
3	Public Health	2	2	60
4	Health Sciences	1	1	21
5	Nursing	1	1	23

Luca Galli

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients Marzia Del Re, Elisa Biasco, Stefania Crucitta, European Urology UrologyEngineeringCancer GenomicsHormonal TherapyProstatic Disease	2016	279
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib Cristian Lolli, Umberto Basso, Lisa Derosa, Oncotarget	2016	150
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis Sergio Bracarda, Roberto Iacovelli, Luca Boni, Annals of Oncology UrologyOncologyGenitourinary CancerMedicineAnti-cancer Agent	2015	105
Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni, Cancer Investigation OncologySkin CancerMelanomaPharmacologyImmunology	2014	104
Long-Acting Depot Lanreotide in the Treatment of Patients With Advanced Neuroendocrine Tumors Serafino Ricci, Andrea Antonuzzo, Luca Galli, American Journal of Clinical Oncology	2000	98
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide Serafino Ricci, Andrea Antonuzzo, Luca Galli, Annals of Oncology OncologyMedicineNeuroendocrine DisorderMetastatic Neuroendocrine TumorsPharmacology	2000	90
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer Andrea Fontana, Luca Galli, Anna Fioravanti, Clinical Cancer Research	2009	88
[18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results Francesco Pasqualetti, M. Panichi, A. Sainato, Radiation Oncology	2016	84
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme Ugo De Giorgi, Giacomo Cartenì, Diana Giannarelli, British Journal of Urology	2018	82
Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis Paolo Grassi, Ludovic Doucet, Palma Giglione, PLoS ONE	2016	73

Page 1